US20080196730A1 - Smokeless Tobacco Product - Google Patents
Smokeless Tobacco Product Download PDFInfo
- Publication number
- US20080196730A1 US20080196730A1 US11/571,477 US57147705A US2008196730A1 US 20080196730 A1 US20080196730 A1 US 20080196730A1 US 57147705 A US57147705 A US 57147705A US 2008196730 A1 US2008196730 A1 US 2008196730A1
- Authority
- US
- United States
- Prior art keywords
- vehicle
- smokeless tobacco
- tobacco product
- product according
- tobacco
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Definitions
- the present invention relates generally to a smokeless tobacco product in the form of a completely dissolvable vehicle comprising concentrated tobacco extract contained in a dissolvable matrix.
- Smokeless tobacco e.g. so called “snuff”
- smokeless tobacco is widely used as substitute for cigarettes, cigars and other forms of smoking-tobacco as it poses comparatively less health risks to the user.
- Many people do also use a smokeless alternative during a transition period to reduce the acute abstinence from nicotine that may results from a sudden refraining from cigarettes.
- the general object of the present invention is to provide a more appealing administration form for smokeless tobacco.
- Another object of the invention is to provide a vehicle that, in the mouth of a user, releases flavours coming from tobacco extracts as well as other substances, which vehicle provides for a controlled release and thereby intake of these flavours and substances.
- a further object is to provide a three-dimensional vehicle which in the mouth of a user creates a three-dimensional sensation.
- the dissolvable vehicle comprising a water-soluble polymer matrix in which tobacco extract has been incorporated.
- the tobacco extract has been freed from any type of insoluble residue, and the whole vehicle will therefore dissolve within the mouth of a user.
- the necessity of an unpleasant and discomfortable removal of a saliva-soaked tobacco pouch is thereby eliminated.
- the dissolvable vehicle is a three-dimensional vehicle, which in the mouth of a user creates a three-dimensional sensation.
- the dissolvable three-dimensional vehicle has a multilayer structure, with at least one layer comprising a water-soluble polymer matrix in which concentrated tobacco extract has been incorporated.
- Another layer of the three-dimensional vehicle may comprise different kinds of flavours, additives, and other drugs such as nicotine.
- a multilayered three-dimensional vehicle is adapted to dissolve layer by layer, thereby providing for a controlled release and subsequent intake of the drugs and flavours contained in the respective layers.
- FIG. 1 is a schematic illustration of a first embodiment of the present invention.
- FIG. 2 is a schematic illustration of a second embodiment of the present invention.
- FIG. 3 illustrates schematically the dimensions of a vehicle according to one embodiment of the present invention.
- the present invention relates to a smokeless tobacco product in the form of a dissolvable vehicle comprising a water-soluble polymer matrix containing concentrated tobacco extract.
- the polymer matrix is made from any type of water-soluble polymer, including both synthetic and naturally occurring polymeric substances.
- the matrix is formulated to optimize the leaching process of the various flavour substances found in tobacco extracts.
- the dissolvable vehicle is a body with significant extensions in all three dimensions, such that the dissolvable vehicle at the start of the dissolution process creates a three-dimensional feeling in a user's mouth.
- suitable water-soluble polymers are various proteins such as collagen or fibrin, and various carbohydrates like alginates, guar gum, agarose, as well as various types of glucosamino-glucanes and cellulose. It can be noted that most of these carbohydrates can be chemically substituted to significantly alter their properties.
- Various types of polymeric alcohols such as polyethylene glycols, polypropylene glycols, and polyvinyl alcohols, can be used to formulate the water-soluble matrix as well as polypyrollidone, and various polymeric acrylic acids and ionomers.
- polyethylene glycols polypropylene glycols
- polyvinyl alcohols can be used to formulate the water-soluble matrix as well as polypyrollidone, and various polymeric acrylic acids and ionomers.
- Several of the alternatives listed above can be cross-linked in various degrees to achieve alterations in their dissolution properties. It is further possible to incorporate various types of non-ionic, cationic and/or anionic substituents in the polymer matrix to
- the dissolvable vehicle may be a multilayer vehicle.
- one of the layers preferably the outermost layer, can comprise a component with a certain degree of mucoadhesive properties.
- An example of such a mucoadhesive substance is chitosan.
- a mucoadhesive layer would adhere to the mucosa in the mouth of a user, and thereby act as a fixation for the vehicle.
- Such a mucoadhesive substance could also promote the penetration of tobacco flavours into the mucosa.
- soluble or “dissolvable” are meant to encompass all types of disintegrating, dissolving, resorbing, absorbing and eroding processes that can occur in a vehicle that in a user's mouth dissolves in such a way that a removal from the mouth and a subsequent disposal of a vehicle rest by hand are not necessary after the tobacco flavours have been extracted.
- the different substances mentioned above are therefore merely illustrative examples of various ingredients that could be used to formulate a self-disintegrating matrix that constitute a base for a dissolvable vehicle for a smokeless tobacco product.
- the smokeless tobacco product of the present invention is based on concentrated tobacco extract, which can be extracted by several methods well-known in the art.
- Tobacco extract is perhaps most easily prepared by treating tobacco with water, or water containing a small amount of an organic solvent.
- the preferred temperature for extraction is room temperature, but any temperature in the range of 10° C. to 60° C. will work.
- the pH-value and ionic strength can be adjusted to depress or promote extraction of certain tobacco substances.
- Supercritical carbon dioxide has, for example, been successfully employed to produce tobacco extracts that are diminished in nicotine.
- the tobacco extract may include extracts from all original substances of the tobacco plant or a subset thereof, including one or many original substance(s).
- the tobacco extract may be a synthetically prepared substance having essentially equivalent characteristics as the corresponding extract from the tobacco plant.
- the extract may include both one or many original (natural) substance(s) and one or many synthetic substance(s).
- the tobacco extract is nicotine or synthetically prepared nicotine, being the only substance or used in combination with other substances.
- FIG. 1 illustrates a first and basic embodiment of a smokeless tobacco product according to the present invention.
- the tobacco product comprises a vehicle 1 , which is made from a water-soluble polymeric matrix in which tobacco extract has been included.
- the polymeric matrix can be made from any of the polymers listed above.
- One way to formulate such a tobacco-containing polymeric matrix would be to dissolve one or several suitable polymers in a water-solution of tobacco extracts. The solution is then dried to a suitable matrix form. During the drying process the polymers can optionally be cross-linked to alter their dissolution properties.
- a polymer material to be used in the present invention should preferably be soft; it could, for example, have a compression modulus less than 0.1 MPa.
- the polymer material can have a dissolution time ranging from about 5 minutes to about 60 minutes, and preferably from approximately 10 minutes to approximately 30 minutes.
- FIG. 2 a second embodiment of a vehicle 11 for a smokeless tobacco product is shown.
- the vehicle 11 is a multi-layer vehicle that comprises an inner layer 12 , an intermediate layer 13 , and an outer layer 14 .
- the inner layer 12 comprises a water-soluble polymeric matrix in which tobacco extract has been included.
- the matrix can be formulated in the same way as suggested in conjunction with FIG. 1 , or the polymeric matrix can be in the form of a porous or fibrous matrix in which dry tobacco extract or water-dissolved tobacco extract is incorporated.
- the intermediate layer 13 can then serve as a cover or seal that encapsulates the tobacco extract inside the polymeric matrix.
- the intermediate layer 13 can further comprise a swelling substance that absorbs saliva and thereby increases the volume of the vehicle 11 . Any type of cross-linked carbohydrates could be used as a swelling substance.
- the outer layer 14 can comprise an adhesive, such as chitosan, which adhere to the mucosa in a user's mouth, and thereby fixates the vehicle 11 inside the user's mouth.
- the outer layer 14 can also comprise a substance that facilitates the penetration of the flavours and other drugs and substances into the mucosa.
- the structure of the vehicle 11 is only exemplifying, and it should in particular be recognized that more layers could be added, and that the contents of each layer could be altered such that, for example, the swelling substance is in the innermost layer, while the tobacco extract is contained in an intermediate layer.
- the different layers can be based on the same polymer matrix, the only difference being that different additives, such as drugs and flavours, are included in the different layers, with at least one layer containing the tobacco extract.
- Another possibility is to prepare a special polymeric matrix for each layer to thereby make it easy to control the dissolution of the layer and the release of substances therefrom.
- one layer e.g. the outermost layer, in the form of a dragée, which further can comprise a substance which renders this layer a special effect on the user.
- An advantage of having a multilayer vehicle is that the separate layers can be adapted to dissolve sequentially in a user's mouth.
- on outer layer is essentially disintegrated before an inner layer starts to dissolve. It is thereby easy to control the effect that the present vehicle has on a user.
- the outermost layer could include a high concentration of nicotine, as the desire for nicotine presumably is at the highest just after the user has put the vehicle in his or her mouth, while a more interior layer could include a lower concentration of nicotine, when the user's urge for nicotine has been almost satisfied. The total intake of nicotine could thereby be reduced.
- the present invention is not restricted to any particular dimensions of a vehicle for a smokeless tobacco product.
- the vehicle can, for example, be in the form of an essentially two-dimensional structure such as a thin sheet or patch. It is, however, the present inventors' belief that for some people it is important that a smokeless tobacco product for oral administration is capable of creating a three-dimensional sensation in the mouth of a user.
- the term “three-dimensional” is defined as a dimensional relationship that creates a three-dimensional sensation in a user's mouth.
- the vehicle for the tobacco extract has therefore a first dimension (e.g. a length), a second dimension (e.g. a width) and a third dimensions (e.g. a height), and is characterized in that none of the three dimensions is negligible in comparison with one of the other two dimensions.
- a first dimension e.g. a length
- a second dimension e.g. a width
- a third dimensions e.g. a height
- FIG. 3 shows a schematic view of the vehicle according to the present invention.
- A is about 30 mm
- B is about 15 mm
- C is about 5 mm, such that C/A ⁇ 1 ⁇ 6.
- a vehicle according to the present invention is pillowshaped, and provided with rounded corners and/or edges, as can be seen in FIG. 1 or FIG. 2 .
- the three-dimensional sensation referred to above relates to a three-dimensional sensation created when the vehicle has been placed in the mouth of a user.
- the vehicle can be essentially two-dimensional before it is placed in the user's mouth. This would in particular apply to a vehicle comprising a swelling substance. Such a vehicle would then perhaps not fulfil the above criteria for A, B and C before it has been placed in the mouth, but would fulfil these criteria shortly after it has come into contact with salvia. Also such vehicles are considered to be three-dimensional vehicles.
- a vehicle containing tobacco extract can comprise a large variety of different drugs.
- a drug is nicotine, which can be included in different, selectable concentrations in different versions of the smokeless tobacco product of the present invention.
- the nicotine concentration could, for example, range from a high concentration to zero, such that people, e.g. inveterate smokers, gradually can reduce their daily intake and finally get rid of their nicotine addiction.
- the smokeless tobacco product could also be flavoured with extra flavours, such as liquorice, menthol, spearmint or peppermint. It is also possible to add vitamins and minerals to create a healthier product. More dedicated drugs could also be added. Examples of such drugs would be flour or a suitable teeth-whitening substance, or a substance that cures halitosis, or some other type of nature-cure drug.
Abstract
Description
- The present invention relates generally to a smokeless tobacco product in the form of a completely dissolvable vehicle comprising concentrated tobacco extract contained in a dissolvable matrix.
- Smokeless tobacco, e.g. so called “snuff”, is widely used as substitute for cigarettes, cigars and other forms of smoking-tobacco as it poses comparatively less health risks to the user. Many people do also use a smokeless alternative during a transition period to reduce the acute abstinence from nicotine that may results from a sudden refraining from cigarettes.
- To make such tobacco more user-friendly, it is known to confine the tobacco in a small non-dissolvable, permeable pouch, which is kept in the mouth until the tobacco flavours have been extracted from the tobacco and which is then removed. It is, however, also well-known that many people find the use of such tobacco pouches little appealing or even repulsive, mainly because of the necessity to remove the saliva soaked and soggy tobacco pouch from the mouth and then dispose the same. The discomfort is, of course, even more pronounced if the smokeless tobacco is used in a public environment, such as meeting rooms, restaurants or other restricted areas, where it can be difficult or even impossible to dispose the used tobacco pouch in a discreet and hygienic way. Needless to say, these people are even less appealed by smokeless tobacco that is not contained in such a pouch.
- For the mucosal administration of drugs such as nicotine, drug delivering vehicles in the forms of membranes or patches are known. When such membranes or patches are used for the oral administration of drugs, they do not, however, create a three-dimensional sensation in the user's mouth. It is the present inventors' belief that such a three-dimensional sensation is crucial for some people's acceptance of smokeless tobacco products.
- A more appealing smokeless tobacco product is therefore needed.
- Today smokeless tobacco is sold in the form of non-dissolvable tobacco-filled permeable pouches, which a user keeps in his or her mouth until the flavours have been extracted from the tobacco and which the user then removes with his/her fingers, something that many people find unappealing.
- The general object of the present invention is to provide a more appealing administration form for smokeless tobacco.
- Another object of the invention is to provide a vehicle that, in the mouth of a user, releases flavours coming from tobacco extracts as well as other substances, which vehicle provides for a controlled release and thereby intake of these flavours and substances.
- A further object is to provide a three-dimensional vehicle which in the mouth of a user creates a three-dimensional sensation.
- These objects are achieved with a dissolvable vehicle comprising a water-soluble polymer matrix in which tobacco extract has been incorporated. The tobacco extract has been freed from any type of insoluble residue, and the whole vehicle will therefore dissolve within the mouth of a user. The necessity of an unpleasant and discomfortable removal of a saliva-soaked tobacco pouch is thereby eliminated. In one embodiment of the invention, the dissolvable vehicle is a three-dimensional vehicle, which in the mouth of a user creates a three-dimensional sensation.
- According to a preferred embodiment of the present invention, the dissolvable three-dimensional vehicle has a multilayer structure, with at least one layer comprising a water-soluble polymer matrix in which concentrated tobacco extract has been incorporated. Another layer of the three-dimensional vehicle may comprise different kinds of flavours, additives, and other drugs such as nicotine. In one embodiment of the invention, a multilayered three-dimensional vehicle is adapted to dissolve layer by layer, thereby providing for a controlled release and subsequent intake of the drugs and flavours contained in the respective layers.
-
FIG. 1 is a schematic illustration of a first embodiment of the present invention. -
FIG. 2 is a schematic illustration of a second embodiment of the present invention. -
FIG. 3 illustrates schematically the dimensions of a vehicle according to one embodiment of the present invention. - The present invention relates to a smokeless tobacco product in the form of a dissolvable vehicle comprising a water-soluble polymer matrix containing concentrated tobacco extract. The polymer matrix is made from any type of water-soluble polymer, including both synthetic and naturally occurring polymeric substances. The matrix is formulated to optimize the leaching process of the various flavour substances found in tobacco extracts. In one embodiment of the invention, the dissolvable vehicle is a body with significant extensions in all three dimensions, such that the dissolvable vehicle at the start of the dissolution process creates a three-dimensional feeling in a user's mouth.
- Examples of suitable water-soluble polymers are various proteins such as collagen or fibrin, and various carbohydrates like alginates, guar gum, agarose, as well as various types of glucosamino-glucanes and cellulose. It can be noted that most of these carbohydrates can be chemically substituted to significantly alter their properties. Various types of polymeric alcohols, such as polyethylene glycols, polypropylene glycols, and polyvinyl alcohols, can be used to formulate the water-soluble matrix as well as polypyrollidone, and various polymeric acrylic acids and ionomers. Several of the alternatives listed above can be cross-linked in various degrees to achieve alterations in their dissolution properties. It is further possible to incorporate various types of non-ionic, cationic and/or anionic substituents in the polymer matrix to yield satisfying dissolution properties, and also to accelerate or retard the leaching process of a specific tobacco flavour.
- As already indicated above, the dissolvable vehicle may be a multilayer vehicle. In that case, one of the layers, preferably the outermost layer, can comprise a component with a certain degree of mucoadhesive properties. An example of such a mucoadhesive substance is chitosan. A mucoadhesive layer would adhere to the mucosa in the mouth of a user, and thereby act as a fixation for the vehicle. Such a mucoadhesive substance could also promote the penetration of tobacco flavours into the mucosa.
- As used herein, the terms “soluble” or “dissolvable” are meant to encompass all types of disintegrating, dissolving, resorbing, absorbing and eroding processes that can occur in a vehicle that in a user's mouth dissolves in such a way that a removal from the mouth and a subsequent disposal of a vehicle rest by hand are not necessary after the tobacco flavours have been extracted. The different substances mentioned above are therefore merely illustrative examples of various ingredients that could be used to formulate a self-disintegrating matrix that constitute a base for a dissolvable vehicle for a smokeless tobacco product.
- The smokeless tobacco product of the present invention is based on concentrated tobacco extract, which can be extracted by several methods well-known in the art. Tobacco extract is perhaps most easily prepared by treating tobacco with water, or water containing a small amount of an organic solvent. The preferred temperature for extraction is room temperature, but any temperature in the range of 10° C. to 60° C. will work. Also the pH-value and ionic strength can be adjusted to depress or promote extraction of certain tobacco substances. Supercritical carbon dioxide has, for example, been successfully employed to produce tobacco extracts that are diminished in nicotine.
- The tobacco extract may include extracts from all original substances of the tobacco plant or a subset thereof, including one or many original substance(s). In addition, and within the scope of the present invention as it is defined by the claims, the tobacco extract may be a synthetically prepared substance having essentially equivalent characteristics as the corresponding extract from the tobacco plant. Naturally, the extract may include both one or many original (natural) substance(s) and one or many synthetic substance(s).
- According to a preferred embodiment the tobacco extract is nicotine or synthetically prepared nicotine, being the only substance or used in combination with other substances.
- Below exemplifying embodiments of a vehicle for a smokeless tobacco product are described with reference to the accompanying drawings.
-
FIG. 1 illustrates a first and basic embodiment of a smokeless tobacco product according to the present invention. The tobacco product comprises avehicle 1, which is made from a water-soluble polymeric matrix in which tobacco extract has been included. The polymeric matrix can be made from any of the polymers listed above. One way to formulate such a tobacco-containing polymeric matrix would be to dissolve one or several suitable polymers in a water-solution of tobacco extracts. The solution is then dried to a suitable matrix form. During the drying process the polymers can optionally be cross-linked to alter their dissolution properties. A polymer material to be used in the present invention should preferably be soft; it could, for example, have a compression modulus less than 0.1 MPa. The polymer material can have a dissolution time ranging from about 5 minutes to about 60 minutes, and preferably from approximately 10 minutes to approximately 30 minutes. InFIG. 2 , a second embodiment of avehicle 11 for a smokeless tobacco product is shown. In this embodiment, thevehicle 11 is a multi-layer vehicle that comprises aninner layer 12, anintermediate layer 13, and anouter layer 14. Here, theinner layer 12 comprises a water-soluble polymeric matrix in which tobacco extract has been included. The matrix can be formulated in the same way as suggested in conjunction withFIG. 1 , or the polymeric matrix can be in the form of a porous or fibrous matrix in which dry tobacco extract or water-dissolved tobacco extract is incorporated. Theintermediate layer 13 can then serve as a cover or seal that encapsulates the tobacco extract inside the polymeric matrix. Theintermediate layer 13 can further comprise a swelling substance that absorbs saliva and thereby increases the volume of thevehicle 11. Any type of cross-linked carbohydrates could be used as a swelling substance. Theouter layer 14 can comprise an adhesive, such as chitosan, which adhere to the mucosa in a user's mouth, and thereby fixates thevehicle 11 inside the user's mouth. Theouter layer 14 can also comprise a substance that facilitates the penetration of the flavours and other drugs and substances into the mucosa. The structure of thevehicle 11 is only exemplifying, and it should in particular be recognized that more layers could be added, and that the contents of each layer could be altered such that, for example, the swelling substance is in the innermost layer, while the tobacco extract is contained in an intermediate layer. - When the vehicle is a multilayer vehicle, the different layers can be based on the same polymer matrix, the only difference being that different additives, such as drugs and flavours, are included in the different layers, with at least one layer containing the tobacco extract. Another possibility is to prepare a special polymeric matrix for each layer to thereby make it easy to control the dissolution of the layer and the release of substances therefrom. It is also conceivable to apply one layer, e.g. the outermost layer, in the form of a dragée, which further can comprise a substance which renders this layer a special effect on the user.
- An advantage of having a multilayer vehicle is that the separate layers can be adapted to dissolve sequentially in a user's mouth. In other words, on outer layer is essentially disintegrated before an inner layer starts to dissolve. It is thereby easy to control the effect that the present vehicle has on a user. As an example, the outermost layer could include a high concentration of nicotine, as the desire for nicotine presumably is at the highest just after the user has put the vehicle in his or her mouth, while a more interior layer could include a lower concentration of nicotine, when the user's urge for nicotine has been almost satisfied. The total intake of nicotine could thereby be reduced.
- The present invention is not restricted to any particular dimensions of a vehicle for a smokeless tobacco product. The vehicle can, for example, be in the form of an essentially two-dimensional structure such as a thin sheet or patch. It is, however, the present inventors' belief that for some people it is important that a smokeless tobacco product for oral administration is capable of creating a three-dimensional sensation in the mouth of a user. As used herein, the term “three-dimensional” is defined as a dimensional relationship that creates a three-dimensional sensation in a user's mouth.
- As an example, most of the plasters and patches known in the prior art do not fulfil this criterion. In one embodiment of the present invention, the vehicle for the tobacco extract has therefore a first dimension (e.g. a length), a second dimension (e.g. a width) and a third dimensions (e.g. a height), and is characterized in that none of the three dimensions is negligible in comparison with one of the other two dimensions. When such a vehicle is placed in a user's mouth, the user will experience a sensation that the vehicle occupies space in all three dimensions. When, for example, placed between a lip and teeth or gums, the vehicle would slightly stretch the user's lip to provide essentially the same sensation that is created by a conventional tobacco pouch.
- If a vehicle for the mucosal administration of tobacco extracts has a length denoted by A, a width denoted by B, and a height denoted by C, and if A is larger than (or equal to) B, then C should be at least one tenth of A (i.e. C/A≧ 1/10), preferably C/A≧ 1/7. A suitable interval for C/A could be ⅛≦C/A≦½.
FIG. 3 shows a schematic view of the vehicle according to the present invention. - In one embodiment A is about 30 mm, B is about 15 mm, and C is about 5 mm, such that C/A≈⅙. Preferably, a vehicle according to the present invention is pillowshaped, and provided with rounded corners and/or edges, as can be seen in
FIG. 1 orFIG. 2 . - Here it can be noted that the three-dimensional sensation referred to above relates to a three-dimensional sensation created when the vehicle has been placed in the mouth of a user. In other words, the vehicle can be essentially two-dimensional before it is placed in the user's mouth. This would in particular apply to a vehicle comprising a swelling substance. Such a vehicle would then perhaps not fulfil the above criteria for A, B and C before it has been placed in the mouth, but would fulfil these criteria shortly after it has come into contact with salvia. Also such vehicles are considered to be three-dimensional vehicles.
- Although the present invention has been described with reference to specific embodiments, also shown in the appended drawings, it will be apparent for those skilled in the art that many variations and modifications can be done within the scope of the invention as described in the specification and defined with reference to the claims below. It should in particular be recognized that a vehicle containing tobacco extract can comprise a large variety of different drugs. One example of such a drug is nicotine, which can be included in different, selectable concentrations in different versions of the smokeless tobacco product of the present invention. The nicotine concentration could, for example, range from a high concentration to zero, such that people, e.g. inveterate smokers, gradually can reduce their daily intake and finally get rid of their nicotine addiction. The smokeless tobacco product could also be flavoured with extra flavours, such as liquorice, menthol, spearmint or peppermint. It is also possible to add vitamins and minerals to create a healthier product. More dedicated drugs could also be added. Examples of such drugs would be flour or a suitable teeth-whitening substance, or a substance that cures halitosis, or some other type of nature-cure drug.
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/571,477 US20080196730A1 (en) | 2004-07-02 | 2005-06-08 | Smokeless Tobacco Product |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58449404P | 2004-07-02 | 2004-07-02 | |
SE0401721-674 | 2004-07-02 | ||
SE0401721A SE0401721D0 (en) | 2004-07-02 | 2004-07-02 | Drug releasing three-dimensional vehicle |
PCT/SE2005/000864 WO2006004480A1 (en) | 2004-07-02 | 2005-06-08 | Smokeless toabacco product |
US11/571,477 US20080196730A1 (en) | 2004-07-02 | 2005-06-08 | Smokeless Tobacco Product |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080196730A1 true US20080196730A1 (en) | 2008-08-21 |
Family
ID=35783173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/571,477 Abandoned US20080196730A1 (en) | 2004-07-02 | 2005-06-08 | Smokeless Tobacco Product |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080196730A1 (en) |
EP (1) | EP1765309B1 (en) |
AT (1) | ATE438390T1 (en) |
DE (1) | DE602005015854D1 (en) |
WO (1) | WO2006004480A1 (en) |
Cited By (167)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070012328A1 (en) * | 2005-04-29 | 2007-01-18 | Philip Morris Usa Inc. | Tobacco pouch product |
US20070261707A1 (en) * | 2005-04-29 | 2007-11-15 | Philip Morris Usa Inc. | Tobacco pouch product |
US20080302682A1 (en) * | 2007-06-11 | 2008-12-11 | Radi Medical Biodegradable Ab | Pouch for tobacco or tobacco substitute |
US20090022917A1 (en) * | 2007-07-16 | 2009-01-22 | Philip Morris Usa Inc. | Oral delivery pouch product with coated seam |
US20090035414A1 (en) * | 2007-07-16 | 2009-02-05 | Philip Morris Usa Inc. | Method of flavor encapsulation through the use of a drum coater |
US20100300464A1 (en) * | 2008-12-18 | 2010-12-02 | Philip Morris Usa Inc. | Moist botanical pouch processing and moist oral botanical pouch products |
US20100300463A1 (en) * | 2009-06-02 | 2010-12-02 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US20100300465A1 (en) * | 2007-06-08 | 2010-12-02 | Zimmermann Stephen G | Oral Pouch Products Including a Liner and Tobacco Beads |
US20110048434A1 (en) * | 2009-06-02 | 2011-03-03 | R. J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
WO2011087954A1 (en) | 2010-01-12 | 2011-07-21 | R. J. Reynolds Tobacco Company | Dispensing container |
WO2011088171A2 (en) | 2010-01-15 | 2011-07-21 | R. J. Reynolds Tobacco Company | Tobacco-derived components and materials |
US20110180087A1 (en) * | 2008-12-30 | 2011-07-28 | Philip Morris Usa Inc. | Oral pouch product with multi-layered pouch wrapper |
WO2011127182A1 (en) | 2010-04-08 | 2011-10-13 | R. J. Reynolds Tobacco Company | Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material |
WO2011133633A1 (en) | 2010-04-21 | 2011-10-27 | R. J. Reynolds Tobacco Company | Tobacco seed-derived components and materials |
US8067046B2 (en) | 2007-06-08 | 2011-11-29 | Philip Morris Usa Inc. | Oral pouch product including soluble dietary fibers |
WO2012021504A2 (en) | 2010-08-11 | 2012-02-16 | R. J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
US8124147B2 (en) | 2007-07-16 | 2012-02-28 | Philip Morris Usa Inc. | Oral pouch products with immobilized flavorant particles |
WO2012030946A1 (en) | 2010-09-02 | 2012-03-08 | R. J. Reynolds Tobacco Company | Apparatus for manufacturing a smokeless tobacco product incorporating an object, and associated method |
WO2012033743A1 (en) | 2010-09-07 | 2012-03-15 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
US20120067361A1 (en) * | 2009-04-03 | 2012-03-22 | X-International Aps | Plant fiber product and method for its manufacture |
WO2012068375A1 (en) | 2010-11-18 | 2012-05-24 | R. J. Reynolds Tobacco Company | Fire-cured tobacco extract and tobacco products made therefrom |
WO2012075035A2 (en) | 2010-12-01 | 2012-06-07 | R. J. Reynolds Tobacco Company | Smokeless tobacco pastille and moulding process for forming smokeless tobacco products |
WO2012074985A1 (en) | 2010-12-01 | 2012-06-07 | R. J. Reynolds Tobacco Company | Tobacco separation process for extracting tobacco-derived materials, and associated extraction systems |
WO2012074865A1 (en) | 2010-12-01 | 2012-06-07 | R. J. Reynolds Tobacco Company | Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products |
WO2012083127A1 (en) | 2010-12-17 | 2012-06-21 | R. J. Reynolds Tobacco Company | Tobacco-derived syrup composition |
WO2012103435A1 (en) | 2011-01-28 | 2012-08-02 | R. J. Reynolds Tobacco Company | Tobacco-derived casing composition |
WO2012103327A1 (en) | 2011-01-28 | 2012-08-02 | R. J. Reynolds Tobacco Company | Polymeric materials derived from tobacco |
WO2012106237A1 (en) | 2011-01-31 | 2012-08-09 | American Snuff Company, Llc | Container for smokeless tobacco products |
WO2012148996A1 (en) | 2011-04-27 | 2012-11-01 | R. J. Reynolds Tobacco Company | Tobacco-derived components and materials |
WO2012158915A2 (en) | 2011-05-19 | 2012-11-22 | R. J. Reynolds Tobacco Company | Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles |
WO2013043835A2 (en) | 2011-09-22 | 2013-03-28 | R. J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US8424541B2 (en) | 2007-07-16 | 2013-04-23 | Philip Morris Usa Inc. | Tobacco-free oral flavor delivery pouch product |
WO2013074903A1 (en) | 2011-11-18 | 2013-05-23 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising tobacco - derived pectin component |
WO2013074315A1 (en) | 2011-11-17 | 2013-05-23 | R.J. Reynolds Tobacco Company | Method for producing triethyl citrate from tobacco |
WO2013074742A2 (en) | 2011-11-16 | 2013-05-23 | R. J. Reynolds Tobacco Company | Smokeless tobacco products with starch component |
WO2013090366A2 (en) | 2011-12-14 | 2013-06-20 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
WO2013096408A1 (en) | 2011-12-20 | 2013-06-27 | R. J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
WO2013119799A1 (en) | 2012-02-10 | 2013-08-15 | R. J. Reynolds Tobacco Company | Multi-layer smokeless tobacco composition |
WO2013122948A1 (en) | 2012-02-13 | 2013-08-22 | R. J. Reynolds Tobacco Company | Whitened tobacco composition |
WO2013142483A1 (en) | 2012-03-19 | 2013-09-26 | R. J. Reynolds Tobacco Company | Method for treating an extracted tobacco pulp and tobacco products made therefrom |
WO2013155177A1 (en) | 2012-04-11 | 2013-10-17 | R. J. Reynolds Tobacco Company | Method for treating plants with probiotics |
WO2013158957A1 (en) | 2012-04-19 | 2013-10-24 | R. J. Reynolds Tobacco Company | Method for producing microcrystalline cellulose from tobacco and related tobacco product |
WO2013166285A1 (en) | 2012-05-04 | 2013-11-07 | R. J. Reynolds Tobacco Company | Transparent moisture barrier coatings for containers |
WO2013192519A1 (en) | 2012-06-22 | 2013-12-27 | R. J. Reynolds Tobacco Company | Composite tobacco-containing materials |
US8616221B2 (en) | 2007-02-28 | 2013-12-31 | Philip Morris Usa Inc. | Oral pouch product with flavored wrapper |
WO2014015228A1 (en) | 2012-07-19 | 2014-01-23 | R. J. Reynolds Tobacco Company | Method for treating tobacco plants with enzymes |
US8685478B2 (en) | 2005-11-21 | 2014-04-01 | Philip Morris Usa Inc. | Flavor pouch |
WO2014058837A1 (en) | 2012-10-09 | 2014-04-17 | R. J. Reynolds Tobacco Company | Tobacco-derived o-methylated flavonoid composition |
US8747562B2 (en) | 2009-10-09 | 2014-06-10 | Philip Morris Usa Inc. | Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release |
WO2014138223A1 (en) | 2013-03-07 | 2014-09-12 | R.J. Reynolds Tobacco Company | Method for producing lutein from tobacco |
WO2014150926A1 (en) | 2013-03-14 | 2014-09-25 | R. J. Reynolds Tobacco Company | Sugar-enriched extract derived from tobacco |
WO2014159617A1 (en) | 2013-03-14 | 2014-10-02 | R. J. Reynolds Tobacco Company | Protein-enriched tobacco-derived composition |
WO2014165760A1 (en) | 2013-04-05 | 2014-10-09 | R. J. Reynolds Tobacco Company | Modification of bacterial profile of tobacco |
US8863755B2 (en) | 2009-02-27 | 2014-10-21 | Philip Morris Usa Inc. | Controlled flavor release tobacco pouch products and methods of making |
WO2015017613A1 (en) | 2013-08-02 | 2015-02-05 | R.J. Reynolds Tobacco Company | Process for producing lignin from tobacco |
US8950408B2 (en) | 2007-07-16 | 2015-02-10 | Philip Morris Usa Inc. | Oral pouch product having soft edge |
WO2015021137A1 (en) | 2013-08-08 | 2015-02-12 | R. J. Reynolds Tobacco Company | Tobacco-derived pyrolysis oil |
US8991403B2 (en) | 2009-06-02 | 2015-03-31 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
WO2015077219A2 (en) | 2013-11-20 | 2015-05-28 | R. J. Reynolds Tobacco Company | Container for smokeless tobacco product |
WO2015109085A1 (en) | 2014-01-17 | 2015-07-23 | R.J. Reynolds Tobacco Company | Process for producing flavorants and related materials |
US9126704B2 (en) | 2010-04-12 | 2015-09-08 | Altria Client Services Inc. | Pouch product with improved seal and method |
WO2015183801A1 (en) | 2014-05-27 | 2015-12-03 | R. J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
US9386800B2 (en) | 2012-09-21 | 2016-07-12 | R.J. Reynolds Tobacco Company | Fibrous composite tobacco-containing materials |
WO2016200804A1 (en) | 2015-06-10 | 2016-12-15 | R. J. Reynolds Tobacco Company | Container for smokeless tobacco products comprising a pulp material and related packaged product assembly and method |
WO2017040785A2 (en) | 2015-09-02 | 2017-03-09 | R.J. Reynolds Tobacco Company | System and apparatus for reducing tobacco-specific nitrosamines in dark-fire cured tobacco through electronic control of curing conditions |
WO2017040789A1 (en) | 2015-09-02 | 2017-03-09 | R.J. Reynolds Tobacco Company | Method for monitoring use of a tobacco product |
US9591875B2 (en) | 2012-09-21 | 2017-03-14 | R. J. Reynolds Tobacco Company | Fibrous composite tobacco-containing materials |
WO2017044466A1 (en) | 2015-09-08 | 2017-03-16 | R. J. Reynolds Tobacco Company | High-pressure cold pasteurization of tobacco material |
WO2017044558A1 (en) | 2015-09-09 | 2017-03-16 | R. J. Reynolds Tobacco Company | Flavor delivery article |
WO2017098439A1 (en) | 2015-12-10 | 2017-06-15 | R. J. Reynolds Tobacco Company | Protein-enriched tobacco composition |
WO2017103795A1 (en) | 2015-12-16 | 2017-06-22 | R. J. Reynolds Tobacco Company | Flavor additive accessory |
WO2017115234A1 (en) | 2015-12-28 | 2017-07-06 | R. J. Reynolds Tobacco Company | Package for a tobacco-containing material and related packaging method |
WO2017120073A1 (en) | 2016-01-05 | 2017-07-13 | R.J. Reynolds Tobacco Company | Smokeless tobacco product |
WO2017130161A1 (en) | 2016-01-28 | 2017-08-03 | R. J. Reynolds Tobacco Company | Tobacco-derived flavorants |
WO2018015872A1 (en) | 2016-07-18 | 2018-01-25 | R. J. Reynolds Tobacco Company | Nonwoven composite smokeless tobacco product |
WO2018109660A2 (en) | 2016-12-12 | 2018-06-21 | R. J. Reynolds Tobacco Company | Dehydration of tobacco and tobacco-derived materials |
US10039311B2 (en) * | 2014-10-17 | 2018-08-07 | Securience, LLC | Tobacco extract for non-combustible smoking devices |
WO2018185708A1 (en) | 2017-04-06 | 2018-10-11 | R. J. Reynolds Tobacco Company | Smoke treatment |
WO2019049049A1 (en) | 2017-09-05 | 2019-03-14 | R. J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
US10329068B2 (en) | 2016-05-23 | 2019-06-25 | R.J. Reynolds Tobacco Company | Flavoring mechanism for a tobacco related material |
US10357054B2 (en) | 2013-10-16 | 2019-07-23 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
WO2019162903A1 (en) | 2018-02-23 | 2019-08-29 | American Snuff Company, Llc | Container for smokeless tobacco products |
WO2019193580A1 (en) | 2018-04-05 | 2019-10-10 | R. J. Reynolds Tobacco Company | Oriental tobacco production methods |
WO2019198055A2 (en) | 2018-04-13 | 2019-10-17 | R. J. Reynolds Tobacco Company | Lid for a container for smokeless tobacco products |
US10561168B2 (en) | 2010-01-15 | 2020-02-18 | R.J. Reynolds Tobacco Company | Tobacco-derived components and materials |
WO2020128971A1 (en) | 2018-12-20 | 2020-06-25 | R. J. Reynolds Tobacco Company | Method for whitening tobacco |
WO2020225768A1 (en) | 2019-05-09 | 2020-11-12 | American Snuff Company, Llc | Stabilizer for moist snuff |
US10881133B2 (en) | 2015-04-16 | 2021-01-05 | R.J. Reynolds Tobacco Company | Tobacco-derived cellulosic sugar |
WO2021048770A1 (en) | 2019-09-11 | 2021-03-18 | Nicoventures Trading Limited | Alternative methods for whitening tobacco |
WO2021050741A1 (en) | 2019-09-11 | 2021-03-18 | R. J. Reynolds Tobacco Company | Oral product with a basic amine and an ion pairing agent |
WO2021048769A1 (en) | 2019-09-13 | 2021-03-18 | Nicoventures Trading Limited | Method for whitening tobacco |
WO2021048768A1 (en) | 2019-09-11 | 2021-03-18 | Nicoventures Trading Limited | Method for whitening tobacco |
WO2021048792A1 (en) | 2019-09-11 | 2021-03-18 | R. J. Reynolds Tobacco Company | Oral product with cellulosic flavor stabilizer |
EP3794963A1 (en) | 2019-09-18 | 2021-03-24 | American Snuff Company, LLC | Method for fermenting tobacco |
WO2021086367A1 (en) | 2019-10-31 | 2021-05-06 | Nicoventures Trading Limited | Oral product and method of manufacture |
WO2021116866A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Pouched products with enhanced flavor stability |
WO2021116822A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with reduced irritation |
WO2021116862A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral compositions with reduced water content |
WO2021116837A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Pouched products |
WO2021116865A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Agents for oral composition |
WO2021116878A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
WO2021116916A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product with multiple flavors having different release profiles |
WO2021116884A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Layered fleece for pouched product |
WO2021116853A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Fibrous fleece material |
WO2021116890A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Liquid composition for oral use or for use in an aerosol delivery device |
WO2021116834A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Nanoemulsion for oral use |
WO2021116824A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product comprising a cannabinoid |
WO2021116841A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Moist oral compositions |
WO2021116895A2 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Stimulus-responsive pouch |
WO2021116825A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product |
WO2021116918A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral compositions including gels |
WO2021116894A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Pouched products with heat sealable binder |
WO2021116876A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral composition with salt inclusion |
WO2021116881A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product in a pourous pouch comprising a fleece material |
WO2021116891A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral foam composition |
WO2021116914A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral composition with polymeric component |
WO2021116856A2 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products |
WO2021116887A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Lipid-containing oral composition |
WO2021116917A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral composition with nanocrystalline cellulose |
WO2021116868A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with controlled release |
WO2021116892A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral compositions with reduced water activity |
WO2021116879A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral composition with beet material |
WO2021116919A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Fleece for oral product with releasable component |
WO2021116852A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product with dissolvable component |
WO2021116854A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with active ingredient combinations |
WO2021116893A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product and method of manufacture |
WO2021116826A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product comprising a cannabinoid |
WO2021116855A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral compositions and methods of manufacture |
WO2021116823A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product |
WO2021116867A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Buffered oral compositions |
WO2021116827A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Process |
WO2021116842A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with controlled release |
US11091446B2 (en) | 2017-03-24 | 2021-08-17 | R.J. Reynolds Tobacco Company | Methods of selectively forming substituted pyrazines |
WO2021250516A1 (en) | 2020-06-08 | 2021-12-16 | Nicoventures Trading Limited | Effervescent oral composition comprising an active ingredient |
WO2022043700A1 (en) | 2020-08-27 | 2022-03-03 | Nicoventures Trading Limited | Oral product |
WO2022049536A1 (en) | 2020-09-04 | 2022-03-10 | Nicoventures Trading Limited | Method for whitening tobacco |
WO2022049545A1 (en) | 2020-09-04 | 2022-03-10 | Nicoventures Trading Limited | Child-resistant container for tobacco-containing products |
WO2022053982A1 (en) | 2020-09-11 | 2022-03-17 | Nicoventures Trading Limited | Alginate-based substrates |
US11278050B2 (en) | 2017-10-20 | 2022-03-22 | R.J. Reynolds Tobacco Company | Methods for treating tobacco and tobacco-derived materials to reduce nitrosamines |
WO2022107031A1 (en) | 2020-11-19 | 2022-05-27 | Nicoventures Trading Limited | Oral products |
WO2022112949A1 (en) | 2020-11-25 | 2022-06-02 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
WO2022190042A1 (en) | 2021-03-12 | 2022-09-15 | Nicoventures Trading Limited | Oral products with self-emulsifying system |
WO2022189977A1 (en) | 2021-03-09 | 2022-09-15 | Nicoventures Trading Limited | Oral products and methods of manufacture |
WO2022224198A1 (en) | 2021-04-22 | 2022-10-27 | Nicoventures Trading Limited | Oral lozenge products |
WO2022224196A1 (en) | 2021-04-22 | 2022-10-27 | Nicoventures Trading Limited | Orally dissolving films |
WO2022224200A1 (en) | 2021-04-22 | 2022-10-27 | Nicoventures Trading Limited | Oral compositions and methods of manufacture |
WO2022224197A1 (en) | 2021-04-22 | 2022-10-27 | Nicoventures Trading Limited | Effervescent oral composition |
WO2022229929A1 (en) | 2021-04-30 | 2022-11-03 | Nicoventures Trading Limited | Oral products with high-density load |
WO2022229926A1 (en) | 2021-04-30 | 2022-11-03 | Nicoventures Trading Limited | Multi-compartment oral pouched product |
WO2022234522A1 (en) | 2021-05-06 | 2022-11-10 | Nicoventures Trading Limited | Oral compositions and related methods for reducing throat irritation |
US11503853B2 (en) | 2013-09-09 | 2022-11-22 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition incorporating a botanical material |
WO2022264066A1 (en) | 2021-06-16 | 2022-12-22 | Nicoventures Trading Limited | Pouched product comprising dissolvable composition |
WO2022269556A1 (en) | 2021-06-25 | 2022-12-29 | Nicoventures Trading Limited | Oral products and method of manufacture |
WO2022269475A1 (en) | 2021-06-21 | 2022-12-29 | Nicoventures Trading Limited | Oral product tablet and method of manufacture |
WO2023281469A1 (en) | 2021-07-09 | 2023-01-12 | Nicoventures Trading Limited | Extruded structures |
WO2023002439A1 (en) | 2021-07-22 | 2023-01-26 | Nicoventures Trading Limited | Nanoemulsion comprising cannabinoid and/or cannabimimetic |
WO2023053060A1 (en) | 2021-09-30 | 2023-04-06 | Nicoventures Trading Limited | Oral gum composition |
WO2023053062A1 (en) | 2021-09-30 | 2023-04-06 | Nicoventures Trading Limited | Oral product with a basic amine and an ion pairing agent |
WO2023084499A1 (en) | 2021-11-15 | 2023-05-19 | Nicoventures Trading Limited | Products with enhanced sensory characteristics |
WO2023084498A1 (en) | 2021-11-15 | 2023-05-19 | Nicoventures Trading Limited | Oral products with nicotine-polymer complex |
WO2023194959A1 (en) | 2022-04-06 | 2023-10-12 | Nicoventures Trading Limited | Pouched products with heat sealable binder |
WO2023199282A1 (en) | 2022-04-14 | 2023-10-19 | Nicoventures Trading Limited | Container for oral products |
EP4282779A1 (en) | 2014-10-16 | 2023-11-29 | R.J. Reynolds Tobacco Company | Package for a tobacco-containing material with a valve assembly and related packaging method |
WO2023248187A1 (en) | 2022-06-24 | 2023-12-28 | Nicoventures Trading Limited | Oral composition comprising a receptor modulator |
US11877590B2 (en) | 2019-03-27 | 2024-01-23 | Fiedler & Lundgren Ab | Smokeless tobacco composition |
EP4338735A2 (en) | 2015-11-25 | 2024-03-20 | R. J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
WO2024069373A1 (en) | 2022-09-26 | 2024-04-04 | Nicoventures Trading Limited | Child-resistant container for tobacco-containing products |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US8469036B2 (en) | 2003-11-07 | 2013-06-25 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
WO2007084587A2 (en) * | 2006-01-20 | 2007-07-26 | Monosol Rx, Llc | Film lined pouch and method of manufacturing this pouch |
US9032971B2 (en) | 2006-11-15 | 2015-05-19 | Philip Morris Usa Inc. | Moist tobacco product and method of making |
US8029837B2 (en) | 2007-06-08 | 2011-10-04 | Philip Morris Usa Inc. | Chewable pouch for flavored product delivery |
WO2009004488A2 (en) | 2007-06-08 | 2009-01-08 | Philip Morris Products S.A. | Capsule clusters for oral consumption |
US8312886B2 (en) | 2007-08-09 | 2012-11-20 | Philip Morris Usa Inc. | Oral tobacco product having a hydrated membrane coating and a high surface area |
US8469037B2 (en) | 2008-02-08 | 2013-06-25 | Philip Morris Usa Inc. | Pre-portioned moist product and method of making |
US20100116281A1 (en) | 2008-11-07 | 2010-05-13 | Jerry Wayne Marshall | Tobacco products and processes |
US9155772B2 (en) | 2008-12-08 | 2015-10-13 | Philip Morris Usa Inc. | Soft, chewable and orally dissolvable and/or disintegrable products |
US9167835B2 (en) | 2008-12-30 | 2015-10-27 | Philip Morris Usa Inc. | Dissolvable films impregnated with encapsulated tobacco, tea, coffee, botanicals, and flavors for oral products |
US9167847B2 (en) | 2009-03-16 | 2015-10-27 | Philip Morris Usa Inc. | Production of coated tobacco particles suitable for usage in a smokeless tobacoo product |
US9848634B2 (en) | 2009-06-30 | 2017-12-26 | Philip Morris Products S.A. | Smokeless tobacco product |
US9687023B2 (en) | 2009-10-09 | 2017-06-27 | Philip Morris Usa Inc. | Moist smokeless tobacco product for oral usage having on a portion of the outer surface at least one friction reducing strip that provides texture during use |
US8539958B2 (en) | 2009-10-13 | 2013-09-24 | Philip Morris Usa Inc. | Oral moist smokeless tobacco products with net-structured gel coating and methods of making |
US8640714B2 (en) | 2009-11-12 | 2014-02-04 | Philip Morris Usa Inc. | Oral chewable tobacco product and method of manufacture thereof |
US8905243B2 (en) | 2010-08-11 | 2014-12-09 | R.J. Reynolds Tobacco Company | Apparatus for sorting objects, and associated method |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
US8931493B2 (en) | 2010-11-01 | 2015-01-13 | R.J. Reynolds Tobacco Co. | Smokeless tobacco products |
US20160044955A1 (en) | 2014-08-13 | 2016-02-18 | R.J. Reynolds Tobacco Company | Smokeless tobacco products |
CN116250483B (en) | 2015-06-26 | 2024-01-30 | 奥驰亚客户服务公司 | Compositions and methods for producing tobacco plants and articles having altered alkaloid content |
WO2017192921A1 (en) | 2016-05-05 | 2017-11-09 | Monosol Rx, Llc | Enhanced delivery epinephrine compositions |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3795654A (en) * | 1971-12-20 | 1974-03-05 | Union Carbide Corp | Degradable polyolefin film |
US5167244A (en) * | 1990-01-19 | 1992-12-01 | Kjerstad Randy E | Tobacco substitute |
US5346734A (en) * | 1993-04-16 | 1994-09-13 | Bethanie K. Wydick | Perforated latex oral pouch for loose snuff |
US5540962A (en) * | 1992-10-16 | 1996-07-30 | Leonard Pearlstein | Degradable package for containment of liquids |
US5760049A (en) * | 1997-02-21 | 1998-06-02 | Synapse Pharmaceuticals International, Inc. | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use |
US5783207A (en) * | 1985-05-01 | 1998-07-21 | University Of Utah Research Foundation | Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine |
US6041483A (en) * | 1997-05-15 | 2000-03-28 | Design Cast Studios Llc | Funerary urn |
US6162516A (en) * | 1995-10-11 | 2000-12-19 | Derr; Dedric M. | System and method for protecting oral tissues from smokeless tobacco |
US20030118692A1 (en) * | 2001-10-22 | 2003-06-26 | Yadong Wang | Biodegradable polymer |
US6670521B2 (en) * | 2000-04-20 | 2003-12-30 | The Procter & Gamble Company | Dispersible absorbent products and methods of manufacture and use |
US20040178104A1 (en) * | 2001-05-22 | 2004-09-16 | Uni-Charm Corporation | Interlabial pad individual packaging body |
US20050136112A1 (en) * | 2003-12-19 | 2005-06-23 | Pediamed Pharmaceuticals, Inc. | Oral medicament delivery system |
US20050136155A1 (en) * | 2003-12-22 | 2005-06-23 | Jordan Joy F. | Specialty beverage infusion package |
US7021848B1 (en) * | 1999-10-08 | 2006-04-04 | The Procter & Gamble Company | Semi-enclosed applicator having a temperature changing element |
US20060260973A1 (en) * | 2003-06-20 | 2006-11-23 | Plantic Technologies Ltd. | Easy open water soluble blister package |
US20070012328A1 (en) * | 2005-04-29 | 2007-01-18 | Philip Morris Usa Inc. | Tobacco pouch product |
US20070031539A1 (en) * | 2005-08-02 | 2007-02-08 | Calton Jim S Jr | Personal caffeine delivery pouch |
US20070062549A1 (en) * | 2005-09-22 | 2007-03-22 | Holton Darrell E Jr | Smokeless tobacco composition |
US20070186941A1 (en) * | 2006-02-10 | 2007-08-16 | Holton Darrell E Jr | Smokeless tobacco composition |
US20080029116A1 (en) * | 2006-08-01 | 2008-02-07 | John Howard Robinson | Smokeless tobacco |
US20080302682A1 (en) * | 2007-06-11 | 2008-12-11 | Radi Medical Biodegradable Ab | Pouch for tobacco or tobacco substitute |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4855326A (en) * | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
AU5751799A (en) * | 1998-09-09 | 2000-03-27 | Quadrant Holdings Cambridge Limited | Filamentous amorphous carbohydrate compositions and therapeutic delivery vehicles comprising them |
DE10157124A1 (en) * | 2001-11-21 | 2003-05-28 | Lohmann Therapie Syst Lts | Controlled release device useful for e.g. oral or transdermal administration of pharmaceuticals comprises a microfiber including releasable active material |
ATE353633T1 (en) * | 2002-12-19 | 2007-03-15 | Pharmacia Corp | NON-HYGROSCOPIC FORMULATION CONTAINING A HYGROSCOPIC ACTIVE INGREDIENT |
-
2005
- 2005-06-08 EP EP05752156A patent/EP1765309B1/en not_active Revoked
- 2005-06-08 US US11/571,477 patent/US20080196730A1/en not_active Abandoned
- 2005-06-08 AT AT05752156T patent/ATE438390T1/en not_active IP Right Cessation
- 2005-06-08 WO PCT/SE2005/000864 patent/WO2006004480A1/en active Application Filing
- 2005-06-08 DE DE602005015854T patent/DE602005015854D1/en active Active
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3795654A (en) * | 1971-12-20 | 1974-03-05 | Union Carbide Corp | Degradable polyolefin film |
US5783207A (en) * | 1985-05-01 | 1998-07-21 | University Of Utah Research Foundation | Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine |
US5167244A (en) * | 1990-01-19 | 1992-12-01 | Kjerstad Randy E | Tobacco substitute |
US5540962A (en) * | 1992-10-16 | 1996-07-30 | Leonard Pearlstein | Degradable package for containment of liquids |
US5346734A (en) * | 1993-04-16 | 1994-09-13 | Bethanie K. Wydick | Perforated latex oral pouch for loose snuff |
US6162516A (en) * | 1995-10-11 | 2000-12-19 | Derr; Dedric M. | System and method for protecting oral tissues from smokeless tobacco |
US5760049A (en) * | 1997-02-21 | 1998-06-02 | Synapse Pharmaceuticals International, Inc. | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use |
US6041483A (en) * | 1997-05-15 | 2000-03-28 | Design Cast Studios Llc | Funerary urn |
US7021848B1 (en) * | 1999-10-08 | 2006-04-04 | The Procter & Gamble Company | Semi-enclosed applicator having a temperature changing element |
US6670521B2 (en) * | 2000-04-20 | 2003-12-30 | The Procter & Gamble Company | Dispersible absorbent products and methods of manufacture and use |
US20040178104A1 (en) * | 2001-05-22 | 2004-09-16 | Uni-Charm Corporation | Interlabial pad individual packaging body |
US20030118692A1 (en) * | 2001-10-22 | 2003-06-26 | Yadong Wang | Biodegradable polymer |
US20060260973A1 (en) * | 2003-06-20 | 2006-11-23 | Plantic Technologies Ltd. | Easy open water soluble blister package |
US20050136112A1 (en) * | 2003-12-19 | 2005-06-23 | Pediamed Pharmaceuticals, Inc. | Oral medicament delivery system |
US20050136155A1 (en) * | 2003-12-22 | 2005-06-23 | Jordan Joy F. | Specialty beverage infusion package |
US20070012328A1 (en) * | 2005-04-29 | 2007-01-18 | Philip Morris Usa Inc. | Tobacco pouch product |
US20070031539A1 (en) * | 2005-08-02 | 2007-02-08 | Calton Jim S Jr | Personal caffeine delivery pouch |
US20070062549A1 (en) * | 2005-09-22 | 2007-03-22 | Holton Darrell E Jr | Smokeless tobacco composition |
US20070186941A1 (en) * | 2006-02-10 | 2007-08-16 | Holton Darrell E Jr | Smokeless tobacco composition |
US20080029116A1 (en) * | 2006-08-01 | 2008-02-07 | John Howard Robinson | Smokeless tobacco |
US20080302682A1 (en) * | 2007-06-11 | 2008-12-11 | Radi Medical Biodegradable Ab | Pouch for tobacco or tobacco substitute |
Cited By (234)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8678015B2 (en) | 2005-04-29 | 2014-03-25 | Philip Morris Usa Inc. | Non-tobacco pouch product |
US20070261707A1 (en) * | 2005-04-29 | 2007-11-15 | Philip Morris Usa Inc. | Tobacco pouch product |
US20070012328A1 (en) * | 2005-04-29 | 2007-01-18 | Philip Morris Usa Inc. | Tobacco pouch product |
US20110203601A1 (en) * | 2005-04-29 | 2011-08-25 | Philip Morris Usa Inc. | Non-tobacco pouch product |
US9044049B2 (en) | 2005-04-29 | 2015-06-02 | Philip Morris Usa Inc. | Tobacco pouch product |
US8671952B2 (en) | 2005-04-29 | 2014-03-18 | Philip Morris Usa Inc. | Tobacco pouch product |
US7980251B2 (en) | 2005-04-29 | 2011-07-19 | Philip Morris Usa Inc. | Method of making pouched tobacco product |
US7950399B2 (en) | 2005-04-29 | 2011-05-31 | Philip Morris Usa Inc. | Non-tobacco pouch product |
US9139360B2 (en) | 2005-11-21 | 2015-09-22 | Philip Morris Usa Inc. | Flavor pouch |
US8685478B2 (en) | 2005-11-21 | 2014-04-01 | Philip Morris Usa Inc. | Flavor pouch |
US9643773B2 (en) | 2005-11-21 | 2017-05-09 | Philip Morris Usa Inc. | Flavor pouch |
US10065794B2 (en) | 2005-11-21 | 2018-09-04 | Philip Morris Usa Inc. | Flavor pouch |
US9345267B2 (en) | 2007-02-28 | 2016-05-24 | Philip Morris Usa Inc. | Oral pouch product with flavored wrapper |
US8616221B2 (en) | 2007-02-28 | 2013-12-31 | Philip Morris Usa Inc. | Oral pouch product with flavored wrapper |
US9061824B2 (en) | 2007-02-28 | 2015-06-23 | Philip Morris Usa Inc. | Oral pouch product with flavored wrapper |
US20100300465A1 (en) * | 2007-06-08 | 2010-12-02 | Zimmermann Stephen G | Oral Pouch Products Including a Liner and Tobacco Beads |
US8067046B2 (en) | 2007-06-08 | 2011-11-29 | Philip Morris Usa Inc. | Oral pouch product including soluble dietary fibers |
US9888712B2 (en) | 2007-06-08 | 2018-02-13 | Philip Morris Usa Inc. | Oral pouch products including a liner and tobacco beads |
US20080302682A1 (en) * | 2007-06-11 | 2008-12-11 | Radi Medical Biodegradable Ab | Pouch for tobacco or tobacco substitute |
US11542049B2 (en) | 2007-07-16 | 2023-01-03 | Philip Morris Usa Inc. | Oral pouch product having soft edge and method of making |
US8202589B2 (en) | 2007-07-16 | 2012-06-19 | Philip Morris Usa Inc. | Oral delivery pouch product with coated seam |
US8124147B2 (en) | 2007-07-16 | 2012-02-28 | Philip Morris Usa Inc. | Oral pouch products with immobilized flavorant particles |
US9889956B2 (en) | 2007-07-16 | 2018-02-13 | Philip Morris Usa Inc. | Oral pouch product having soft edge and method of making |
US20090022917A1 (en) * | 2007-07-16 | 2009-01-22 | Philip Morris Usa Inc. | Oral delivery pouch product with coated seam |
US8950408B2 (en) | 2007-07-16 | 2015-02-10 | Philip Morris Usa Inc. | Oral pouch product having soft edge |
US8424541B2 (en) | 2007-07-16 | 2013-04-23 | Philip Morris Usa Inc. | Tobacco-free oral flavor delivery pouch product |
US10640246B2 (en) | 2007-07-16 | 2020-05-05 | Philip Morris Usa Inc. | Oral pouch product having soft edge and method of making |
US20090035414A1 (en) * | 2007-07-16 | 2009-02-05 | Philip Morris Usa Inc. | Method of flavor encapsulation through the use of a drum coater |
US8701679B2 (en) | 2007-07-16 | 2014-04-22 | Philip Morris Usa Inc. | Tobacco-free oral flavor delivery pouch product |
US8119173B2 (en) | 2007-07-16 | 2012-02-21 | Philip Morris Usa Inc. | Method of flavor encapsulation through the use of a drum coater |
US10492523B2 (en) | 2008-12-17 | 2019-12-03 | Philip Morris Usa Inc. | Moist botanical pouch processing and moist oral botanical pouch products |
US8377215B2 (en) | 2008-12-18 | 2013-02-19 | Philip Morris Usa Inc. | Moist botanical pouch processing |
US20100300464A1 (en) * | 2008-12-18 | 2010-12-02 | Philip Morris Usa Inc. | Moist botanical pouch processing and moist oral botanical pouch products |
US9516894B2 (en) | 2008-12-18 | 2016-12-13 | Philip Morris Usa Inc. | Moist botanical pouch processing and moist oral botanical pouch products |
US20110180087A1 (en) * | 2008-12-30 | 2011-07-28 | Philip Morris Usa Inc. | Oral pouch product with multi-layered pouch wrapper |
US9027567B2 (en) | 2008-12-30 | 2015-05-12 | Philip Morris Usa Inc. | Oral pouch product with multi-layered pouch wrapper |
US8863755B2 (en) | 2009-02-27 | 2014-10-21 | Philip Morris Usa Inc. | Controlled flavor release tobacco pouch products and methods of making |
US20120067361A1 (en) * | 2009-04-03 | 2012-03-22 | X-International Aps | Plant fiber product and method for its manufacture |
US8944072B2 (en) | 2009-06-02 | 2015-02-03 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US20100300463A1 (en) * | 2009-06-02 | 2010-12-02 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US20110048434A1 (en) * | 2009-06-02 | 2011-03-03 | R. J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US8434496B2 (en) | 2009-06-02 | 2013-05-07 | R. J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US8991403B2 (en) | 2009-06-02 | 2015-03-31 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US10143230B2 (en) | 2009-10-09 | 2018-12-04 | Philip Morris Usa Inc. | Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release |
US8747562B2 (en) | 2009-10-09 | 2014-06-10 | Philip Morris Usa Inc. | Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release |
WO2011087954A1 (en) | 2010-01-12 | 2011-07-21 | R. J. Reynolds Tobacco Company | Dispensing container |
US10561168B2 (en) | 2010-01-15 | 2020-02-18 | R.J. Reynolds Tobacco Company | Tobacco-derived components and materials |
US8955523B2 (en) | 2010-01-15 | 2015-02-17 | R.J. Reynolds Tobacco Company | Tobacco-derived components and materials |
WO2011088171A2 (en) | 2010-01-15 | 2011-07-21 | R. J. Reynolds Tobacco Company | Tobacco-derived components and materials |
WO2011127182A1 (en) | 2010-04-08 | 2011-10-13 | R. J. Reynolds Tobacco Company | Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material |
US9039839B2 (en) | 2010-04-08 | 2015-05-26 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material |
US10342251B2 (en) | 2010-04-08 | 2019-07-09 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material |
US9820507B2 (en) | 2010-04-12 | 2017-11-21 | Altria Client Services Llc | Method of making oral pouch product |
US9126704B2 (en) | 2010-04-12 | 2015-09-08 | Altria Client Services Inc. | Pouch product with improved seal and method |
WO2011133633A1 (en) | 2010-04-21 | 2011-10-27 | R. J. Reynolds Tobacco Company | Tobacco seed-derived components and materials |
US10028522B2 (en) | 2010-04-21 | 2018-07-24 | R. J. Reynolds Tobacco Company | Tobacco seed-derived components and materials |
US9402415B2 (en) | 2010-04-21 | 2016-08-02 | R. J. Reynolds Tobacco Company | Tobacco seed-derived components and materials |
US11666083B2 (en) | 2010-08-11 | 2023-06-06 | R.J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
WO2012021504A2 (en) | 2010-08-11 | 2012-02-16 | R. J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
US10772350B2 (en) | 2010-08-11 | 2020-09-15 | R.J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
US11116237B2 (en) | 2010-08-11 | 2021-09-14 | R.J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
US9155321B2 (en) | 2010-08-11 | 2015-10-13 | R.J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
US9993020B2 (en) | 2010-08-11 | 2018-06-12 | R.J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
WO2012021683A2 (en) | 2010-08-12 | 2012-02-16 | R. J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
WO2012030946A1 (en) | 2010-09-02 | 2012-03-08 | R. J. Reynolds Tobacco Company | Apparatus for manufacturing a smokeless tobacco product incorporating an object, and associated method |
US11172702B2 (en) | 2010-09-02 | 2021-11-16 | R. J. Reynolds Tobacco Company | Apparatus for manufacturing a smokeless tobacco product incorporating an object, and associated method |
US10028520B2 (en) | 2010-09-02 | 2018-07-24 | R.J. Reynolds Tobacco Company | Apparatus for manufacturing a smokeless tobacco product incorporating an object, and associated method |
US9675102B2 (en) | 2010-09-07 | 2017-06-13 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
US10537132B2 (en) | 2010-09-07 | 2020-01-21 | R.J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
WO2012033743A1 (en) | 2010-09-07 | 2012-03-15 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
WO2012068375A1 (en) | 2010-11-18 | 2012-05-24 | R. J. Reynolds Tobacco Company | Fire-cured tobacco extract and tobacco products made therefrom |
WO2012074865A1 (en) | 2010-12-01 | 2012-06-07 | R. J. Reynolds Tobacco Company | Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products |
WO2012075035A2 (en) | 2010-12-01 | 2012-06-07 | R. J. Reynolds Tobacco Company | Smokeless tobacco pastille and moulding process for forming smokeless tobacco products |
WO2012074985A1 (en) | 2010-12-01 | 2012-06-07 | R. J. Reynolds Tobacco Company | Tobacco separation process for extracting tobacco-derived materials, and associated extraction systems |
US9220295B2 (en) | 2010-12-01 | 2015-12-29 | R.J. Reynolds Tobacco Company | Tobacco separation process for extracting tobacco-derived materials, and associated extraction systems |
US9775376B2 (en) | 2010-12-01 | 2017-10-03 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille and moulding process for forming smokeless tobacco products |
US9204667B2 (en) | 2010-12-01 | 2015-12-08 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products |
WO2012083127A1 (en) | 2010-12-17 | 2012-06-21 | R. J. Reynolds Tobacco Company | Tobacco-derived syrup composition |
WO2012103435A1 (en) | 2011-01-28 | 2012-08-02 | R. J. Reynolds Tobacco Company | Tobacco-derived casing composition |
US9107453B2 (en) | 2011-01-28 | 2015-08-18 | R.J. Reynolds Tobacco Company | Tobacco-derived casing composition |
WO2012103327A1 (en) | 2011-01-28 | 2012-08-02 | R. J. Reynolds Tobacco Company | Polymeric materials derived from tobacco |
US10159273B2 (en) | 2011-01-28 | 2018-12-25 | R.J. Reynolds Tobacco Company | Tobacco-derived casing composition |
WO2012106237A1 (en) | 2011-01-31 | 2012-08-09 | American Snuff Company, Llc | Container for smokeless tobacco products |
WO2012148996A1 (en) | 2011-04-27 | 2012-11-01 | R. J. Reynolds Tobacco Company | Tobacco-derived components and materials |
EP3545775A1 (en) | 2011-04-27 | 2019-10-02 | R. J. Reynolds Tobacco Company | Method of extracting and isolating compounds from plants of the nicotiana species useful as flavor material |
WO2012158915A2 (en) | 2011-05-19 | 2012-11-22 | R. J. Reynolds Tobacco Company | Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles |
WO2013043835A2 (en) | 2011-09-22 | 2013-03-28 | R. J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
WO2013074742A2 (en) | 2011-11-16 | 2013-05-23 | R. J. Reynolds Tobacco Company | Smokeless tobacco products with starch component |
EP3954229A1 (en) | 2011-11-16 | 2022-02-16 | R. J. Reynolds Tobacco Company | Smokeless tobacco products with starch component |
WO2013074315A1 (en) | 2011-11-17 | 2013-05-23 | R.J. Reynolds Tobacco Company | Method for producing triethyl citrate from tobacco |
WO2013074903A1 (en) | 2011-11-18 | 2013-05-23 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising tobacco - derived pectin component |
WO2013090366A2 (en) | 2011-12-14 | 2013-06-20 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
US11918027B2 (en) | 2011-12-14 | 2024-03-05 | R.J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
US10881132B2 (en) | 2011-12-14 | 2021-01-05 | R.J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
WO2013096408A1 (en) | 2011-12-20 | 2013-06-27 | R. J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
EP3782474A1 (en) | 2011-12-20 | 2021-02-24 | R. J. Reynolds Tobacco Company | Meltable smokeless tobacco composition |
WO2013119799A1 (en) | 2012-02-10 | 2013-08-15 | R. J. Reynolds Tobacco Company | Multi-layer smokeless tobacco composition |
EP3461351A1 (en) | 2012-02-13 | 2019-04-03 | R. J. Reynolds Tobacco Company | Whitend tobacco composition |
WO2013122948A1 (en) | 2012-02-13 | 2013-08-22 | R. J. Reynolds Tobacco Company | Whitened tobacco composition |
WO2013142483A1 (en) | 2012-03-19 | 2013-09-26 | R. J. Reynolds Tobacco Company | Method for treating an extracted tobacco pulp and tobacco products made therefrom |
EP3398457A1 (en) | 2012-04-11 | 2018-11-07 | R. J. Reynolds Tobacco Company | Method for treating plants with probiotics |
WO2013155177A1 (en) | 2012-04-11 | 2013-10-17 | R. J. Reynolds Tobacco Company | Method for treating plants with probiotics |
WO2013158957A1 (en) | 2012-04-19 | 2013-10-24 | R. J. Reynolds Tobacco Company | Method for producing microcrystalline cellulose from tobacco and related tobacco product |
WO2013166285A1 (en) | 2012-05-04 | 2013-11-07 | R. J. Reynolds Tobacco Company | Transparent moisture barrier coatings for containers |
WO2013192519A1 (en) | 2012-06-22 | 2013-12-27 | R. J. Reynolds Tobacco Company | Composite tobacco-containing materials |
US11490650B2 (en) | 2012-06-22 | 2022-11-08 | R.J. Reynolds Tobacco Company | Composite tobacco-containing materials |
WO2014015228A1 (en) | 2012-07-19 | 2014-01-23 | R. J. Reynolds Tobacco Company | Method for treating tobacco plants with enzymes |
US9591875B2 (en) | 2012-09-21 | 2017-03-14 | R. J. Reynolds Tobacco Company | Fibrous composite tobacco-containing materials |
US9386800B2 (en) | 2012-09-21 | 2016-07-12 | R.J. Reynolds Tobacco Company | Fibrous composite tobacco-containing materials |
WO2014058837A1 (en) | 2012-10-09 | 2014-04-17 | R. J. Reynolds Tobacco Company | Tobacco-derived o-methylated flavonoid composition |
WO2014138223A1 (en) | 2013-03-07 | 2014-09-12 | R.J. Reynolds Tobacco Company | Method for producing lutein from tobacco |
WO2014150926A1 (en) | 2013-03-14 | 2014-09-25 | R. J. Reynolds Tobacco Company | Sugar-enriched extract derived from tobacco |
WO2014159617A1 (en) | 2013-03-14 | 2014-10-02 | R. J. Reynolds Tobacco Company | Protein-enriched tobacco-derived composition |
WO2014165760A1 (en) | 2013-04-05 | 2014-10-09 | R. J. Reynolds Tobacco Company | Modification of bacterial profile of tobacco |
WO2015017613A1 (en) | 2013-08-02 | 2015-02-05 | R.J. Reynolds Tobacco Company | Process for producing lignin from tobacco |
WO2015021137A1 (en) | 2013-08-08 | 2015-02-12 | R. J. Reynolds Tobacco Company | Tobacco-derived pyrolysis oil |
US11503853B2 (en) | 2013-09-09 | 2022-11-22 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition incorporating a botanical material |
US10357054B2 (en) | 2013-10-16 | 2019-07-23 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
US10568355B2 (en) | 2013-10-16 | 2020-02-25 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
US11540555B2 (en) | 2013-10-16 | 2023-01-03 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
US10980271B2 (en) | 2013-10-16 | 2021-04-20 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
WO2015077219A2 (en) | 2013-11-20 | 2015-05-28 | R. J. Reynolds Tobacco Company | Container for smokeless tobacco product |
WO2015109085A1 (en) | 2014-01-17 | 2015-07-23 | R.J. Reynolds Tobacco Company | Process for producing flavorants and related materials |
WO2015183801A1 (en) | 2014-05-27 | 2015-12-03 | R. J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
EP3871515A1 (en) | 2014-05-27 | 2021-09-01 | R. J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
EP4282779A1 (en) | 2014-10-16 | 2023-11-29 | R.J. Reynolds Tobacco Company | Package for a tobacco-containing material with a valve assembly and related packaging method |
US10039311B2 (en) * | 2014-10-17 | 2018-08-07 | Securience, LLC | Tobacco extract for non-combustible smoking devices |
US10881133B2 (en) | 2015-04-16 | 2021-01-05 | R.J. Reynolds Tobacco Company | Tobacco-derived cellulosic sugar |
WO2016200804A1 (en) | 2015-06-10 | 2016-12-15 | R. J. Reynolds Tobacco Company | Container for smokeless tobacco products comprising a pulp material and related packaged product assembly and method |
WO2017040789A1 (en) | 2015-09-02 | 2017-03-09 | R.J. Reynolds Tobacco Company | Method for monitoring use of a tobacco product |
WO2017040785A2 (en) | 2015-09-02 | 2017-03-09 | R.J. Reynolds Tobacco Company | System and apparatus for reducing tobacco-specific nitrosamines in dark-fire cured tobacco through electronic control of curing conditions |
WO2017044466A1 (en) | 2015-09-08 | 2017-03-16 | R. J. Reynolds Tobacco Company | High-pressure cold pasteurization of tobacco material |
US10869497B2 (en) | 2015-09-08 | 2020-12-22 | R.J. Reynolds Tobacco Company | High-pressure cold pasteurization of tobacco material |
WO2017044558A1 (en) | 2015-09-09 | 2017-03-16 | R. J. Reynolds Tobacco Company | Flavor delivery article |
EP4338735A2 (en) | 2015-11-25 | 2024-03-20 | R. J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
WO2017098439A1 (en) | 2015-12-10 | 2017-06-15 | R. J. Reynolds Tobacco Company | Protein-enriched tobacco composition |
US11612183B2 (en) | 2015-12-10 | 2023-03-28 | R.J. Reynolds Tobacco Company | Protein-enriched tobacco composition |
WO2017103795A1 (en) | 2015-12-16 | 2017-06-22 | R. J. Reynolds Tobacco Company | Flavor additive accessory |
WO2017115234A1 (en) | 2015-12-28 | 2017-07-06 | R. J. Reynolds Tobacco Company | Package for a tobacco-containing material and related packaging method |
WO2017120073A1 (en) | 2016-01-05 | 2017-07-13 | R.J. Reynolds Tobacco Company | Smokeless tobacco product |
US10499684B2 (en) | 2016-01-28 | 2019-12-10 | R.J. Reynolds Tobacco Company | Tobacco-derived flavorants |
WO2017130161A1 (en) | 2016-01-28 | 2017-08-03 | R. J. Reynolds Tobacco Company | Tobacco-derived flavorants |
US10329068B2 (en) | 2016-05-23 | 2019-06-25 | R.J. Reynolds Tobacco Company | Flavoring mechanism for a tobacco related material |
US10375984B2 (en) | 2016-07-18 | 2019-08-13 | R.J. Reynolds Tobacco Company | Nonwoven composite smokeless tobacco product |
US10588338B2 (en) | 2016-07-18 | 2020-03-17 | R.J. Reynolds Tobacco Company | Nonwoven composite smokeless tobacco product |
WO2018015872A1 (en) | 2016-07-18 | 2018-01-25 | R. J. Reynolds Tobacco Company | Nonwoven composite smokeless tobacco product |
WO2018109660A2 (en) | 2016-12-12 | 2018-06-21 | R. J. Reynolds Tobacco Company | Dehydration of tobacco and tobacco-derived materials |
US11891364B2 (en) | 2017-03-24 | 2024-02-06 | R.J. Reynolds Tobacco Company | Methods of selectively forming substituted pyrazines |
US11091446B2 (en) | 2017-03-24 | 2021-08-17 | R.J. Reynolds Tobacco Company | Methods of selectively forming substituted pyrazines |
WO2018185708A1 (en) | 2017-04-06 | 2018-10-11 | R. J. Reynolds Tobacco Company | Smoke treatment |
WO2019049049A1 (en) | 2017-09-05 | 2019-03-14 | R. J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
US11278050B2 (en) | 2017-10-20 | 2022-03-22 | R.J. Reynolds Tobacco Company | Methods for treating tobacco and tobacco-derived materials to reduce nitrosamines |
WO2019162903A1 (en) | 2018-02-23 | 2019-08-29 | American Snuff Company, Llc | Container for smokeless tobacco products |
WO2019193580A1 (en) | 2018-04-05 | 2019-10-10 | R. J. Reynolds Tobacco Company | Oriental tobacco production methods |
WO2019198055A2 (en) | 2018-04-13 | 2019-10-17 | R. J. Reynolds Tobacco Company | Lid for a container for smokeless tobacco products |
WO2020128971A1 (en) | 2018-12-20 | 2020-06-25 | R. J. Reynolds Tobacco Company | Method for whitening tobacco |
US11877590B2 (en) | 2019-03-27 | 2024-01-23 | Fiedler & Lundgren Ab | Smokeless tobacco composition |
US11213062B2 (en) | 2019-05-09 | 2022-01-04 | American Snuff Company | Stabilizer for moist snuff |
WO2020225768A1 (en) | 2019-05-09 | 2020-11-12 | American Snuff Company, Llc | Stabilizer for moist snuff |
WO2021048791A1 (en) | 2019-09-11 | 2021-03-18 | R. J. Reynolds Tobacco Company | Pouched products with enhanced flavor stability |
WO2021048792A1 (en) | 2019-09-11 | 2021-03-18 | R. J. Reynolds Tobacco Company | Oral product with cellulosic flavor stabilizer |
WO2021048768A1 (en) | 2019-09-11 | 2021-03-18 | Nicoventures Trading Limited | Method for whitening tobacco |
WO2021050741A1 (en) | 2019-09-11 | 2021-03-18 | R. J. Reynolds Tobacco Company | Oral product with a basic amine and an ion pairing agent |
WO2021048770A1 (en) | 2019-09-11 | 2021-03-18 | Nicoventures Trading Limited | Alternative methods for whitening tobacco |
EP4285743A2 (en) | 2019-09-11 | 2023-12-06 | Nicoventures Trading Limited | Oral product with a basic amine and an ion pairing agent |
WO2021048769A1 (en) | 2019-09-13 | 2021-03-18 | Nicoventures Trading Limited | Method for whitening tobacco |
EP3794963A1 (en) | 2019-09-18 | 2021-03-24 | American Snuff Company, LLC | Method for fermenting tobacco |
WO2021086367A1 (en) | 2019-10-31 | 2021-05-06 | Nicoventures Trading Limited | Oral product and method of manufacture |
WO2021116876A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral composition with salt inclusion |
WO2021116825A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product |
WO2021116856A2 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products |
WO2021116887A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Lipid-containing oral composition |
WO2021116917A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral composition with nanocrystalline cellulose |
WO2021116868A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with controlled release |
WO2021116892A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral compositions with reduced water activity |
WO2021116879A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral composition with beet material |
WO2021116919A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Fleece for oral product with releasable component |
WO2021116852A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product with dissolvable component |
WO2021116854A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with active ingredient combinations |
WO2021116893A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product and method of manufacture |
WO2021116826A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product comprising a cannabinoid |
WO2021116855A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral compositions and methods of manufacture |
WO2021116823A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product |
WO2021116867A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Buffered oral compositions |
WO2021116827A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Process |
WO2021116842A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with controlled release |
WO2021116891A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral foam composition |
WO2021116881A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product in a pourous pouch comprising a fleece material |
WO2021116894A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Pouched products with heat sealable binder |
WO2021116918A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral compositions including gels |
WO2021116853A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Fibrous fleece material |
WO2021116890A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Liquid composition for oral use or for use in an aerosol delivery device |
WO2021116895A2 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Stimulus-responsive pouch |
WO2021116884A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Layered fleece for pouched product |
WO2021116834A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Nanoemulsion for oral use |
WO2021116916A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product with multiple flavors having different release profiles |
WO2021116824A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product comprising a cannabinoid |
WO2021116841A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Moist oral compositions |
WO2021116878A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
WO2021116865A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Agents for oral composition |
WO2021116914A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral composition with polymeric component |
WO2021116837A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Pouched products |
WO2021116866A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Pouched products with enhanced flavor stability |
WO2021116822A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with reduced irritation |
WO2021116862A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral compositions with reduced water content |
WO2021250516A1 (en) | 2020-06-08 | 2021-12-16 | Nicoventures Trading Limited | Effervescent oral composition comprising an active ingredient |
WO2022043700A1 (en) | 2020-08-27 | 2022-03-03 | Nicoventures Trading Limited | Oral product |
WO2022049545A1 (en) | 2020-09-04 | 2022-03-10 | Nicoventures Trading Limited | Child-resistant container for tobacco-containing products |
WO2022049536A1 (en) | 2020-09-04 | 2022-03-10 | Nicoventures Trading Limited | Method for whitening tobacco |
WO2022053982A1 (en) | 2020-09-11 | 2022-03-17 | Nicoventures Trading Limited | Alginate-based substrates |
WO2022107031A1 (en) | 2020-11-19 | 2022-05-27 | Nicoventures Trading Limited | Oral products |
WO2022112949A1 (en) | 2020-11-25 | 2022-06-02 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
WO2022189977A1 (en) | 2021-03-09 | 2022-09-15 | Nicoventures Trading Limited | Oral products and methods of manufacture |
WO2022190042A1 (en) | 2021-03-12 | 2022-09-15 | Nicoventures Trading Limited | Oral products with self-emulsifying system |
WO2022224198A1 (en) | 2021-04-22 | 2022-10-27 | Nicoventures Trading Limited | Oral lozenge products |
WO2022224196A1 (en) | 2021-04-22 | 2022-10-27 | Nicoventures Trading Limited | Orally dissolving films |
WO2022224200A1 (en) | 2021-04-22 | 2022-10-27 | Nicoventures Trading Limited | Oral compositions and methods of manufacture |
WO2022224197A1 (en) | 2021-04-22 | 2022-10-27 | Nicoventures Trading Limited | Effervescent oral composition |
WO2022229926A1 (en) | 2021-04-30 | 2022-11-03 | Nicoventures Trading Limited | Multi-compartment oral pouched product |
WO2022229929A1 (en) | 2021-04-30 | 2022-11-03 | Nicoventures Trading Limited | Oral products with high-density load |
WO2022234522A1 (en) | 2021-05-06 | 2022-11-10 | Nicoventures Trading Limited | Oral compositions and related methods for reducing throat irritation |
WO2022264066A1 (en) | 2021-06-16 | 2022-12-22 | Nicoventures Trading Limited | Pouched product comprising dissolvable composition |
WO2022269475A1 (en) | 2021-06-21 | 2022-12-29 | Nicoventures Trading Limited | Oral product tablet and method of manufacture |
WO2022269556A1 (en) | 2021-06-25 | 2022-12-29 | Nicoventures Trading Limited | Oral products and method of manufacture |
WO2023281469A1 (en) | 2021-07-09 | 2023-01-12 | Nicoventures Trading Limited | Extruded structures |
WO2023002439A1 (en) | 2021-07-22 | 2023-01-26 | Nicoventures Trading Limited | Nanoemulsion comprising cannabinoid and/or cannabimimetic |
WO2023053060A1 (en) | 2021-09-30 | 2023-04-06 | Nicoventures Trading Limited | Oral gum composition |
WO2023053062A1 (en) | 2021-09-30 | 2023-04-06 | Nicoventures Trading Limited | Oral product with a basic amine and an ion pairing agent |
WO2023084498A1 (en) | 2021-11-15 | 2023-05-19 | Nicoventures Trading Limited | Oral products with nicotine-polymer complex |
WO2023084499A1 (en) | 2021-11-15 | 2023-05-19 | Nicoventures Trading Limited | Products with enhanced sensory characteristics |
WO2023194959A1 (en) | 2022-04-06 | 2023-10-12 | Nicoventures Trading Limited | Pouched products with heat sealable binder |
WO2023199282A1 (en) | 2022-04-14 | 2023-10-19 | Nicoventures Trading Limited | Container for oral products |
WO2023248187A1 (en) | 2022-06-24 | 2023-12-28 | Nicoventures Trading Limited | Oral composition comprising a receptor modulator |
WO2024069373A1 (en) | 2022-09-26 | 2024-04-04 | Nicoventures Trading Limited | Child-resistant container for tobacco-containing products |
Also Published As
Publication number | Publication date |
---|---|
EP1765309A1 (en) | 2007-03-28 |
WO2006004480A1 (en) | 2006-01-12 |
EP1765309B1 (en) | 2009-08-05 |
DE602005015854D1 (en) | 2009-09-17 |
ATE438390T1 (en) | 2009-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1765309B1 (en) | Smokeless toabacco product | |
EP0749278B1 (en) | Nicotine oral delivery device | |
EP2405942B1 (en) | Oral delivery product | |
JP5283334B2 (en) | Composition material for transmucosal transmission | |
JP5845194B2 (en) | Nicotine-containing soft gelatin troche | |
WO2014093127A2 (en) | Enhanced delivery of nicotine, thc, tobacco, cannabidiol or base alkaloid from an electronic cigarette or other vapor or smoke producing device through use of an absorption conditioning unit | |
US20080166395A1 (en) | Article for delivering substrates to the oral cavity | |
US20140166027A1 (en) | Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor Producing Device Through Use of an Absorption Conditioning Unit | |
US20050034738A1 (en) | Chewing tobacco substitute containing nicotine | |
JP2009527488A (en) | Degradable oral film | |
DE602004017127D1 (en) | LONG-TERM, AROMATED PHARMACEUTICAL FOR THE EXTENDED RELEASE OF ACTIVE SUBSTANCES IN THE MOUTH | |
US20060112965A1 (en) | Chewing tobacco substitute containing cotinine | |
US20100256197A1 (en) | Nicotine Dissolving Film With Or Without Menthol | |
BRPI0711996A2 (en) | Pharmaceutical preparation in the form of a sheet, Use of the pharmaceutical preparation, Use of a combination of active agents, Method for the therapeutic treatment of an individual and Method for the production of a dosage form | |
CN1871953B (en) | Cigarette with tea smell | |
US20080017205A1 (en) | Method and Device for Releasing Flavor and Odor Substances | |
JPH01197435A (en) | Plaster substituting smoking | |
US20140271847A1 (en) | Formulations and methods for rapid penile erections | |
KR100332840B1 (en) | The Antismoking Aid containing an Artemisia | |
CN1741791B (en) | A composition material for transmucosal delivery | |
CN106714815A (en) | Homeopathy preparation for promoting smoker to stop smoking | |
WO2001080672A1 (en) | Method of reducing or quitting smoking | |
CN103040089B (en) | Oral product | |
US20120132218A1 (en) | Smokeless tobacco cessation product | |
Zuccaroli et al. | How to stop smoking: OTC management |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: RADI MEDICAL SYSTEMS AB, SWEDEN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ENGSTROM, THOMAS;MATHISEN, TORBJORN;REEL/FRAME:018852/0336 Effective date: 20070108 |
|
AS | Assignment |
Owner name: RADI MEDICAL BIODEGRADABLE AB, SWEDEN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RADI MEDICAL SYSTEMS AB;REEL/FRAME:019294/0492 Effective date: 20070507 |
|
AS | Assignment |
Owner name: IDAR MEDICAL BIODEGRADABLE AB, SWEDEN Free format text: CHANGE OF NAME;ASSIGNOR:RADI MEDICAL BIODEGRADABLE AB;REEL/FRAME:022695/0859 Effective date: 20090210 |
|
AS | Assignment |
Owner name: NOVUS SCIENTIFIC PTE. LTD., SINGAPORE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IDAR MEDICAL BIODEGRADABLE AB;REEL/FRAME:023851/0795 Effective date: 20091214 Owner name: NOVUS SCIENTIFIC PTE. LTD.,SINGAPORE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IDAR MEDICAL BIODEGRADABLE AB;REEL/FRAME:023851/0795 Effective date: 20091214 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: NOVUS SCIENTIFIC AB, SWEDEN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NOVUS SCIENTIFIC PTE. LTD.;REEL/FRAME:030990/0007 Effective date: 20130722 |